Dr Roberto Salgado
Clinical (Senior Lecturer)
The Sir Peter MacCallum Department of Oncology
528 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma : A report on behalf of the International Immuno-Oncology Biomarker Working Group
DOI: 10.1111/his.700892026
Journal article
World Health Organization classification of tumours of the breast 6th edition 2026.
DOI: 10.1111/his.701492026
Conference Proceedings
Assessment of AI segmentation models in histopathology whole slide images: the effect of the unit of analysis
DOI: 10.1117/12.30859172026
Journal article
Practical consequences of the European union-AI act for anatomic pathology laboratories a European society of pathology and European society of digital and integrative pathology commissioned expert opinion paper
DOI: 10.1007/s00428-025-04291-32026
Journal article
PSMA-targeted PET imaging in patients with metastatic triple-negative breast cancer: results of the prospective PRISMA trial
DOI: 10.1007/s00259-025-07667-42025
Research grants (international)
Validation and Comparison of Computational Pathology-Measured Immune-Biomarkers Using AI-and AI-foundation Models With Patient Level Outcomes in Multiple Randomized Breast Cancer Trials.
2014
Journal article
Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data
DOI: 10.1186/s13059-014-0470-7
RECENT SCHOLARLY WORKS
2026
Journal article
Immunity, age, and luminal breast cancer: understanding the Holy Trinity.
DOI: 10.1158/1078-0432.CCR-25-40352026
Journal article
Clarifying validation terminologies in healthcare.
DOI: 10.1038/s41746-026-02471-22026
Journal article
Analysis of the Radiosensitivity Index in Paired Preneoadjuvant and Postneoadjuvant Therapy Triple-Negative Breast Cancer
DOI: 10.1016/j.ijrobp.2025.09.0382026
Book Chapter
Pathology
DOI: 10.1093/med/9780198911296.003.00132026
Journal article
Abstract PD6-06: Angiogenesis contributes to chemoimmunotherapy resistance in immune-high and immune-low triple-negative breast cancer (TNBC): Biomarker analysis of the NeoPACT trial
DOI: 10.1158/1557-3265.sabcs25-pd6-06